Management of gingival overgrowth associated with generalized enamel defects in a child.
Gingival overgrowth is usually associated with systemic conditions or treatment (e.g. blood dyscrasias, anti-epileptic or immunosuppressive agents). A child is presented, who had enlarged gingiva associated with a generalized enamel defect (amelogenesis imperfecta (AI), hypoplastic type) and document the periodontal and restorative management of this case.
Brennan
M T
MT
Gene Therapy and Therapeutics Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892, USA.
O'Connell
B C
BC
Rams
T E
TE
O'Connell
A C
AC
D000567:Amelogenesis Imperfecta / Q000150:complications* / Q000382:microbiology / Q000628:therapy; D002167:Campylobacter / Q000302:isolation & purification; D002648:Child; D005260:Female; D019214:Gingival Overgrowth / Q000209:etiology* / Q000382:microbiology / Q000628:therapy*; D006801:Humans; D016966:Porphyromonas gingivalis / Q000302:isolation & purification; D018713:Prevotella intermedia / Q000302:isolation & purification